We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$38.4B
1-Year Est. Return
25.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.51%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$50.6B
AUM Growth
–
Cap. Flow
+$50.4B
Cap. Flow
% of AUM
99.68%
Top 10 Holdings %
Top 10 Hldgs %
8.34%
Holding
1,990
New
1,988
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRCL
Stericycle Inc
SRCL
|
+$443M |
| 2 |
TSMC
TSM
|
+$437M |
| 3 |
Idexx Laboratories
IDXX
|
+$407M |
| 4 |
Affiliated Managers Group
AMG
|
+$346M |
| 5 |
Fastenal
FAST
|
+$285M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 8.67% |
| 2 | Technology | 6.78% |
| 3 | Consumer Discretionary | 6.2% |
| 4 | Healthcare | 5.82% |
| 5 | Financials | 5.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Shutterstock
SSTK
$208M
| $16M | 0.03% |
+286,244
| New | +$13.1M |
|
|
EXAR
252
DELISTED
Exar Corporation
EXAR
| $16M | 0.03% |
+1,482,022
| New | +$16.2M |
|
253
CVS Health
CVS
$120B
| $15.9M | 0.03% |
+278,060
| New | +$16.1M |
|
254
Novartis
NVS
$295B
| $15.7M | 0.03% |
+247,664
| New | +$16.1M |
|
255
Intel
INTC
$491B
| $15.5M | 0.03% |
+638,301
| New | +$15.1M |
|
256
Berkshire Hathaway Class A
BRK.A
$1.11T
| $15.3M | 0.03% |
+91
| New | +$15M |
|
257
Cooper Companies
COO
$15B
| $15.3M | 0.03% |
+513,328
| New | +$14.4M |
|
258
Avient
AVNT
$4.21B
| $15.3M | 0.03% |
+615,433
| New | +$15M |
|
|
KMP
259
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
| $15.2M | 0.03% |
+177,398
| New | +$15.4M |
|
|
SPNC
260
DELISTED
Spectranetics Corp
SPNC
| $15.1M | 0.03% |
+810,911
| New | +$15.3M |
|
261
Cisco
CSCO
$475B
| $15.1M | 0.03% |
+620,680
| New | +$14M |
|
|
MDVN
262
DELISTED
MEDIVATION, INC.
MDVN
| $15.1M | 0.03% |
+613,914
| New | +$15.4M |
|
263
Stryker
SYK
$134B
| $15M | 0.03% |
+232,306
| New | +$15.4M |
|
264
Globus Medical
GMED
$11.4B
| $15M | 0.03% |
+887,187
| New | +$13.7M |
|
265
HEICO Corp
HEI
$51.1B
| $14.8M | 0.03% |
+897,165
| New | +$13.7M |
|
266
Emcor
EME
$36B
| $14.5M | 0.03% |
+356,454
| New | +$14M |
|
267
Myriad Genetics
MYGN
$303M
| $14.5M | 0.03% |
+538,847
| New | +$15.6M |
|
268
Pfizer
PFE
$152B
| $14.4M | 0.03% |
+543,166
| New | +$15M |
|
|
ADNC
269
DELISTED
AUDIENCE INC COM STK (DE)
ADNC
| $14.4M | 0.03% |
+1,089,202
| New | +$15.9M |
|
|
COWN
270
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $14.3M | 0.03% |
+1,237,889
| New | +$14M |
|
271
Vanguard Morningstar Value ETF
VTV
$193B
| $14.3M | 0.03% |
+211,575
| New | +$14.3M |
|
272
Merck
MRK
$321B
| $14.3M | 0.03% |
+321,983
| New | +$14.4M |
|
|
NVO
273
Novo Nordisk
NVO
$207B
| $14.2M | 0.03% |
+913,280
| New | +$15.2M |
|
|
ZINC
274
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
| $14.2M | 0.03% |
+1,104,717
| New | +$12.4M |
|
275
Moog Inc Class A
MOG.A
$13.2B
| $14M | 0.03% |
+271,692
| New | +$13.1M |
|
Similar funds
William Blair & Company's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for William Blair & Company, which disclosed 1,990 positions worth $50.6B. Its ten largest holdings account for 8.3% of the portfolio.
Its largest position is Stericycle Inc: 4,074,645 shares worth $450M.
By sector, the portfolio is most concentrated in Industrials at 8.7% of assets, followed by Technology and Consumer Discretionary.
- William Blair & Company's largest Q2 2013 buy was Stericycle Inc: 4,074,645 shares worth $450M.
- William Blair & Company's ten largest holdings make up 8.3% of its $50.6B portfolio in Q2 2013.
- William Blair & Company disclosed 1,990 positions in Q2 2013, its first 13F filing on record.
Based on William Blair & Company's 13F filing for Q2 2013, filed 7 Aug 2013.